{
    "ASSERTIONS": {
        "id": 600,
        "context": "Metastatic castration resistant prostate cancer",
        "description": "The U.S. Food and Drug Administration (FDA) granted approval to olaparib for adult patients with deleterious or suspected deleterous germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC), who have progressed following prior treatment with enzalutamide or abiraterone.",
        "disease": {
            "name": "Prostate Adenocarcinoma",
            "oncotree_code": "PRAD",
            "oncotree_term": "Prostate Adenocarcinoma"
        },
        "therapy_name": "Olaparib",
        "therapy_type": "Targeted therapy",
        "clinical_significance": "sensitivity",
        "predictive_implication": "FDA-Approved",
        "favorable_prognosis": null,
        "created_on": "03/31/21",
        "last_updated": "2020-10-22",
        "submitted_by": "breardon@broadinstitute.org",
        "validated": true,
        "source_ids": 53,
        "variant": {
            "id": 582,
            "alternate_allele": null,
            "cdna_change": null,
            "chromosome": null,
            "end_position": null,
            "exon": null,
            "feature_type": "germline_variant",
            "gene": "BRCA1",
            "pathogenic": "1.0",
            "protein_change": null,
            "reference_allele": null,
            "rsid": null,
            "start_position": null,
            "variant_annotation": null,
            "feature": "BRCA1 (Pathogenic)"
        }
    },
    "SOURCES": {
        "id": 53,
        "type": "FDA",
        "doi": null,
        "nct": "None",
        "pmid": "None",
        "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf",
        "citation": "AstraZeneca Pharmaceuticals, LP. Lynparza (olaparib) [package insert]. U.S. Food and Drug Administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf. Revised May 2020. Accessed 22 October, 2020."
    },
    "VARIANTS": {
        "id": 582,
        "alternate_allele": null,
        "cdna_change": null,
        "chromosome": null,
        "end_position": null,
        "exon": null,
        "feature_type": "germline_variant",
        "gene": "BRCA1",
        "pathogenic": "1.0",
        "protein_change": null,
        "reference_allele": null,
        "rsid": null,
        "start_position": null,
        "variant_annotation": null,
        "feature": "BRCA1 (Pathogenic)"
    }
}